Home ETF List About

Portfolio Holdings Detail for ISIN IE00BD1F4M44
Stock Name / FundiShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerIUVF(GBX) LSE
ETF TickerIUVL(USD) LSE
ETF TickerQDVI(EUR) F
ETF TickerIUVL.LS(USD) CXE
ETF TickerIUVF.L(GBP) LSE
ETF TickerIUVL.L(GBP) LSE

Holdings detail for RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.
(RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP RPRX holdings

DateNumber of RPRX Shares HeldBase Market Value of RPRX SharesLocal Market Value of RPRX SharesChange in RPRX Shares HeldChange in RPRX Base ValueCurrent Price per RPRX Share HeldPrevious Price per RPRX Share Held
2025-11-11 (Tuesday)154,157USD 6,005,957USD 6,005,957
2025-11-10 (Monday)154,157RPRX holding increased by 1859USD 5,941,211RPRX holding increased by 68600USD 5,941,2111,859USD 68,600 USD 38.54 USD 38.56
2025-11-07 (Friday)152,298RPRX holding increased by 845USD 5,872,611RPRX holding decreased by -303642USD 5,872,611845USD -303,642 USD 38.56 USD 40.78
2025-11-06 (Thursday)151,453USD 6,176,253RPRX holding increased by 54523USD 6,176,2530USD 54,523 USD 40.78 USD 40.42
2025-11-05 (Wednesday)151,453USD 6,121,730RPRX holding increased by 390748USD 6,121,7300USD 390,748 USD 40.42 USD 37.84
2025-11-04 (Tuesday)151,453RPRX holding increased by 676USD 5,730,982RPRX holding increased by 107000USD 5,730,982676USD 107,000 USD 37.84 USD 37.3
2025-11-03 (Monday)150,777RPRX holding increased by 169USD 5,623,982RPRX holding decreased by -29842USD 5,623,982169USD -29,842 USD 37.3 USD 37.54
2025-10-31 (Friday)150,608USD 5,653,824RPRX holding increased by 90364USD 5,653,8240USD 90,364 USD 37.54 USD 36.94
2025-10-30 (Thursday)150,608USD 5,563,460RPRX holding increased by 40665USD 5,563,4600USD 40,665 USD 36.94 USD 36.67
2025-10-29 (Wednesday)150,608USD 5,522,795RPRX holding increased by 39158USD 5,522,7950USD 39,158 USD 36.67 USD 36.41
2025-10-28 (Tuesday)150,608USD 5,483,637RPRX holding decreased by -128017USD 5,483,6370USD -128,017 USD 36.41 USD 37.26
2025-10-27 (Monday)150,608USD 5,611,654USD 5,611,6540USD 0 USD 37.26 USD 37.26
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BD1F4M44

Show aggregate share trades of RPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1,85939.39938.510 38.599USD 71,755 32.75
2025-11-07BUY845 38.560* 32.72
2025-11-04BUY67638.08036.755 36.888USD 24,936 32.61
2025-11-03BUY16937.71537.130 37.189USD 6,285 32.58
2025-10-23BUY71636.85037.160 37.129USD 26,584 32.42
2025-10-22SELL-71636.84037.690 37.605USD -26,925 32.39 Loss of -3,732 on sale
2025-10-21SELL-35837.48037.520 37.516USD -13,431 32.37 Loss of -1,844 on sale
2025-10-20BUY17936.63036.920 36.891USD 6,603 32.34
2025-10-17BUY35837.01037.130 37.118USD 13,288 32.32
2025-10-16SELL-53736.34036.450 36.439USD -19,568 32.29 Loss of -2,226 on sale
2025-10-15SELL-35836.18036.270 36.261USD -12,981 32.27 Loss of -1,428 on sale
2025-10-03SELL-1,02036.07036.670 36.610USD -37,342 32.23 Loss of -4,469 on sale
2025-10-02BUY50736.49036.600 36.589USD 18,551 32.20
2025-10-01SELL-50736.32036.455 36.442USD -18,476 32.18 Loss of -2,160 on sale
2025-09-30SELL-16935.28035.540 35.514USD -6,002 32.16 Loss of -566 on sale
2025-09-29SELL-16935.25035.290 35.286USD -5,963 32.14 Loss of -531 on sale
2025-09-25BUY84134.90035.996 35.886USD 30,180 32.11
2025-09-16BUY50735.42035.650 35.627USD 18,063 32.05
2025-09-10BUY50736.18036.760 36.702USD 18,608 32.00
2025-07-28SELL-2,68537.06037.210 37.195USD -99,869 31.90 Loss of -14,206 on sale
2025-07-21SELL-17935.65035.920 35.893USD -6,425 31.77 Loss of -739 on sale
2025-07-17SELL-71635.47035.790 35.758USD -25,603 31.74 Loss of -2,874 on sale
2025-07-16SELL-1,79035.60036.890 36.761USD -65,802 31.72 Loss of -9,026 on sale
2025-07-10SELL-1,79036.12036.560 36.516USD -65,364 31.60 Loss of -8,799 on sale
2025-07-08SELL-1,61135.51035.910 35.870USD -57,787 31.55 Loss of -6,967 on sale
2025-07-07BUY2,14835.59036.420 36.337USD 78,052 31.52
2025-07-03SELL-2,14836.37036.430 36.424USD -78,239 31.45 Loss of -10,680 on sale
2025-06-30SELL-71636.03036.220 36.201USD -25,920 31.39 Loss of -3,447 on sale
2025-06-27BUY17935.87035.931 35.925USD 6,431 31.36
2025-06-25BUY71635.91036.040 36.027USD 25,795 31.30
2025-06-23SELL-35835.40035.455 35.450USD -12,691 31.23 Loss of -1,510 on sale
2025-06-18SELL-1,61134.91034.990 34.982USD -56,356 31.15 Loss of -6,173 on sale
2025-06-17SELL-53734.56035.140 35.082USD -18,839 31.13 Loss of -2,125 on sale
2025-06-13BUY17934.84035.380 35.326USD 6,323 31.07
2025-06-11BUY2,32734.05034.180 34.167USD 79,507 31.01
2025-06-04BUY51633.44033.715 33.688USD 17,383 30.91
2025-06-03SELL-17233.29033.540 33.515USD -5,765 30.89 Loss of -451 on sale
2025-05-30SELL-30,38832.88033.110 33.087USD -1,005,448 30.86 Loss of -67,800 on sale
2025-05-29SELL-20132.64032.770 32.757USD -6,584 30.84 Loss of -385 on sale
2025-05-28SELL-3,83832.63032.820 32.801USD -125,890 30.83 Loss of -7,578 on sale
2025-05-27SELL-7,27232.69032.810 32.798USD -238,507 30.81 Loss of -14,450 on sale
2025-05-23SELL-1,21232.45032.600 32.585USD -39,493 30.78 Loss of -2,184 on sale
2025-05-22SELL-81232.31032.930 32.868USD -26,689 30.77 Loss of -1,704 on sale
2025-05-20SELL-40433.09033.800 33.729USD -13,627 30.73 Loss of -1,211 on sale
2025-05-19SELL-20134.25034.315 34.308USD -6,896 30.70 Loss of -725 on sale
2025-05-16SELL-2,41234.02034.200 34.182USD -82,447 30.67 Loss of -8,467 on sale
2025-05-15BUY3,01533.12033.130 33.129USD 99,884 30.65
2025-05-14BUY60332.29033.110 33.028USD 19,916 30.64
2025-05-12BUY2,41233.35033.600 33.575USD 80,983 30.59
2025-05-09BUY40233.15033.720 33.663USD 13,533 30.57
2025-05-08BUY60333.10034.110 34.009USD 20,507 30.54
2025-05-07BUY60332.75032.825 32.818USD 19,789 30.52
2025-05-06BUY20132.11033.040 32.947USD 6,622 30.51
2025-05-02BUY20432.89032.970 32.962USD 6,724 30.46
2025-04-30BUY61232.82033.000 32.982USD 20,185 30.42
2025-04-25SELL-20332.20032.300 32.290USD -6,555 30.35 Loss of -393 on sale
2025-04-24BUY20332.03032.130 32.120USD 6,520 30.34
2025-04-22SELL-1,02032.19032.730 32.676USD -33,330 30.30 Loss of -2,422 on sale
2025-04-15BUY81232.45032.505 32.500USD 26,390 30.18
2025-04-14BUY40732.29032.320 32.317USD 13,153 30.16
2025-04-11SELL-20331.95032.005 32.000USD -6,496 30.14 Loss of -377 on sale
2025-04-09SELL-1,50532.27032.310 32.306USD -48,621 30.10 Loss of -3,314 on sale
2025-04-08SELL-2,40830.85031.600 31.525USD -75,912 30.09 Loss of -3,444 on sale
2025-04-04BUY2,06431.11031.700 31.641USD 65,307 30.07
2025-04-01BUY29931.17031.505 31.471USD 9,410 30.04
2025-03-31BUY89731.13031.310 31.292USD 28,069 30.03
2025-03-28BUY89731.37031.795 31.753USD 28,482 30.01
2025-03-27BUY89731.65032.250 32.190USD 28,874 29.99
2025-03-26SELL-29931.56034.000 33.756USD -10,093 29.97 Loss of -1,132 on sale
2025-03-24BUY1,80633.75033.990 33.966USD 61,343 29.87
2025-03-21BUY57433.70033.840 33.826USD 19,416 29.82
2025-03-20BUY4,81633.50033.510 33.509USD 161,379 29.77
2025-03-19BUY3,91333.41033.500 33.491USD 131,050 29.72
2025-03-18BUY30133.41033.600 33.581USD 10,108 29.67
2025-03-17SELL-28633.02033.265 33.240USD -9,507 29.62 Loss of -1,036 on sale
2025-03-14SELL-1,21632.77032.955 32.937USD -40,051 29.57 Loss of -4,092 on sale
2025-03-11BUY3,34432.46032.770 32.739USD 109,479 29.43
2025-03-05BUY30133.77033.790 33.788USD 10,170 29.25
2025-02-28BUY4,93933.64033.730 33.721USD 166,548 29.04
2025-02-27BUY29633.37033.620 33.595USD 9,944 28.96
2025-02-26BUY59233.38033.870 33.821USD 20,022 28.89
2025-02-25BUY29633.69034.115 34.073USD 10,085 28.80
2025-02-24BUY1,19233.80034.200 34.160USD 40,719 28.71
2025-02-21SELL-10,51333.42033.670 33.645USD -353,710 28.63 Loss of -52,761 on sale
2025-02-19BUY84332.59032.915 32.883USD 27,720 28.46
2025-02-18SELL-29632.85032.870 32.868USD -9,729 28.38 Loss of -1,329 on sale
2025-02-12BUY19,01232.34032.560 32.538USD 618,612 28.05
2025-02-10SELL-29431.72031.790 31.783USD -9,344 27.87 Loss of -1,149 on sale
2025-02-06SELL-2,34431.40031.625 31.602USD -74,076 27.71 Loss of -9,134 on sale
2025-02-04BUY2,96031.26031.600 31.566USD 93,435 27.53
2025-02-03BUY29631.33031.660 31.627USD 9,362 27.44
2025-01-31SELL-59231.58031.678 31.668USD -18,748 27.34 Loss of -2,565 on sale
2025-01-28BUY28231.94032.120 32.102USD 9,053 26.97
2025-01-23SELL-88830.62030.645 30.643USD -27,211 26.60 Loss of -3,586 on sale
2025-01-02SELL-2,62325.79025.890 25.880USD -67,883 26.63 Profit of 1,966 on sale
2024-12-09BUY29226.01026.220 26.199USD 7,650 26.68
2024-12-06BUY29225.91026.590 26.522USD 7,744 26.71
2024-12-04SELL-1,16826.10026.355 26.329USD -30,753 26.74 Profit of 482 on sale
2024-11-29SELL-2,04426.66026.660 26.660USD -54,493 26.77 Profit of 232 on sale
2024-11-27BUY29126.60026.645 26.641USD 7,752 26.79
2024-11-26SELL-2326.29026.620 26.587USD -612 26.81 Profit of 5 on sale
2024-11-25BUY17,46026.47026.830 26.794USD 467,823 26.83
2024-11-22SELL-51026.43026.630 26.610USD -13,571 26.85 Profit of 121 on sale
2024-11-20SELL-25526.22026.290 26.283USD -6,702 26.91 Profit of 159 on sale
2024-11-12BUY25526.00026.410 26.369USD 6,724 27.10
2024-11-08BUY51026.21026.800 26.741USD 13,638 27.17
2024-11-07BUY1,02026.52027.030 26.979USD 27,519 27.21
2024-11-06BUY49026.64028.360 28.188USD 13,812 27.26
2024-11-04BUY3,70527.20027.593 27.554USD 102,086 27.24
2024-11-01SELL-25327.10027.270 27.253USD -6,895 27.26 Profit of 1 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19877,43501,269,34869.1%
2025-09-18854,1562551,225,70969.7%
2025-09-17890,42801,130,88978.7%
2025-09-16849,69101,371,04262.0%
2025-09-151,310,0518751,800,47672.8%
2025-09-121,066,1208001,339,29279.6%
2025-09-111,220,1202831,532,65679.6%
2025-09-101,195,1197901,440,33383.0%
2025-09-091,259,8539241,521,80482.8%
2025-09-081,967,2801,0943,312,54759.4%
2025-09-052,792,92604,789,48758.3%
2025-09-04649,49701,396,64246.5%
2025-09-03741,51103,964,24418.7%
2025-09-021,164,4616211,836,12263.4%
2025-08-29568,8486441,099,44151.7%
2025-08-28343,4431,229665,67251.6%
2025-08-27718,529151,134,79763.3%
2025-08-26376,8063,158782,11648.2%
2025-08-25523,36001,666,11631.4%
2025-08-22416,9751,403983,55642.4%
2025-08-21515,9061789,60565.3%
2025-08-20668,9345571,359,61949.2%
2025-08-19282,3631,211801,13935.2%
2025-08-18470,777713735,14364.0%
2025-08-15370,8860849,95543.6%
2025-08-14437,27101,270,82534.4%
2025-08-13450,93002,187,21920.6%
2025-08-12378,7083211,366,73627.7%
2025-08-11566,6033221,321,77142.9%
2025-08-08732,3041,1411,058,55269.2%
2025-08-07637,7791411,478,11943.1%
2025-08-06968,026951,335,30672.5%
2025-08-05817,147971,153,95670.8%
2025-08-04562,562677830,96467.7%
2025-08-01356,771847641,24655.6%
2025-07-31550,713210657,91283.7%
2025-07-30529,655432816,35164.9%
2025-07-29600,85925752,37279.9%
2025-07-28682,7281,073824,97582.8%
2025-07-25351,99350514,20168.5%
2025-07-24396,41057557,22971.1%
2025-07-23289,2172,996787,22036.7%
2025-07-22460,4210666,17169.1%
2025-07-21489,8451,682693,05470.7%
2025-07-18355,3760587,43460.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.